FFS
IHI icon

Founders Financial Securities’s iShares US Medical Devices ETF IHI Stock Holding History

Founders Financial Securities’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Sell
4,968
-150
-3% -$8.81K 0.02% 471
2025
Q4 		$318K Sell
5,118
-988
-16% -$61K 0.02% 468
2025
Q3 		$367K Sell
6,106
-148
-2% -$9.05K 0.03% 391
2025
Q2 		$392K Sell
6,254
-824
-12% -$49.5K 0.03% 379
2025
Q1 		$421K Sell
7,078
-1,248
-15% -$77.5K 0.04% 340
2024
Q4 		$486K Sell
8,326
-612
-7% -$36.4K 0.04% 308
2024
Q3 		$529K Sell
8,938
-2,168
-20% -$124K 0.05% 262
2024
Q2 		$622K Sell
11,106
-4,350
-28% -$243K 0.06% 248
2024
Q1 		$906K Sell
15,456
-2,702
-15% -$153K 0.1% 176
2023
Q4 		$980K Sell
18,158
-7,015
-28% -$343K 0.11% 168
2023
Q3 		$1.22M Buy
25,173
+1,425
+6% +$75.8K 0.16% 116
2023
Q2 		$1.34M Sell
23,748
-63
-0.3% -$3.47K 0.18% 111
2023
Q1 		$1.29M Sell
23,811
-1,116
-4% -$59.4K 0.19% 109
2022
Q4 		$1.31M Sell
24,927
-121
-0.5% -$6.14K 0.21% 100
2022
Q3 		$1.18M Buy
25,048
+1,568
+7% +$81.4K 0.21% 100
2022
Q2 		$1.18M Sell
23,480
-3,058
-12% -$167K 0.23% 88
2022
Q1 		$1.62M Buy
26,538
+498
+2% +$29.7K 0.29% 74
2021
Q4 		$1.72M Buy
26,040
+2,774
+12% +$178K 0.31% 73
2021
Q3 		$1.46M Buy
23,266
+460
+2% +$29.3K 0.29% 71
2021
Q2 		$1.37M Buy
22,806
+336
+1% +$19.4K 0.27% 79
2021
Q1 		$1.24M Buy
22,470
+1,608
+8% +$89.2K 0.29% 70
2020
Q4 		$1.14M Buy
20,862
+2,124
+11% +$111K 0.27% 62
2020
Q3 		$936K Buy
+18,738
New +$907K 0.3% 58
2018
Q4 		– Sell
-151,188
Closed -$5.73M – 108
2018
Q3 		$5.73M Buy
151,188
+3,450
+2% +$123K 1.59% 19
2018
Q2 		$4.94M Buy
+147,738
New +$4.81M 1.52% 19
2017
Q3 		– Sell
-62,880
Closed -$1.75M – 96
2017
Q2 		$1.75M Sell
62,880
-2,856
-4% -$75.6K 0.66% 31
2017
Q1 		$1.66M Buy
+65,736
New +$1.59M 0.63% 33
2016
Q3 		– Sell
-171,504
Closed -$3.88M – 89
2016
Q2 		$3.88M Buy
+171,504
New +$3.71M 1.78% 16

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Founders Financial Securities's IHI Position: Q1 2026 in Review

Founders Financial Securities reduced its iShares US Medical Devices ETF (IHI) stake by 2.9% in Q1 2026, selling an estimated $8.81K and leaving 4,968 shares worth $267K. The position accounts for 0.02% of the portfolio, ranked #471.

Founders Financial Securities first reported a position in IHI in Q2 2016 and has held it in 28 quarters since. The position peaked at $5.73M in Q3 2018. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Founders Financial Securities held 4,968 shares of iShares US Medical Devices ETF worth $267K as of Q1 2026.
  • Founders Financial Securities sold 150 iShares US Medical Devices ETF shares in Q1 2026, an estimated $8.81K.
  • iShares US Medical Devices ETF made up 0.02% of Founders Financial Securities's portfolio in Q1 2026, its #471 holding.
  • Founders Financial Securities first reported a position in iShares US Medical Devices ETF in Q2 2016 and has held it in 28 quarters since.
  • Founders Financial Securities's iShares US Medical Devices ETF position peaked at $5.73M in Q3 2018.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Founders Financial Securities's 13F filing for Q1 2026, filed 16 Apr 2026.